Ionis Pharmaceuticals, Inc. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/12bfec10-1d80-4524-85eb-e5a0180fcfd7/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-381.4M | 2025-01-01 – 2025-12-31 | evidence 0000874015-26-000115 |
| FY 2024 | $-453.9M | 2024-01-01 – 2024-12-31 | evidence 0000874015-25-000089 |
| FY 2023 | $-366.3M | 2023-01-01 – 2023-12-31 | evidence 0000874015-24-000116 |
| FY 2022 | $-269.7M | 2022-01-01 – 2022-12-31 | evidence 0000874015-23-000105 |
| FY 2021 | $-28.6M | 2021-01-01 – 2021-12-31 | evidence 0000874015-22-000079 |
| FY 2020 | $-444.3M | 2020-01-01 – 2020-12-31 | evidence 0000874015-22-000079 |
| FY 2019 | $278.1M | 2019-01-01 – 2019-12-31 | evidence 0000874015-22-000079 |
| FY 2018 | $273.7M | 2018-01-01 – 2018-12-31 | evidence 0000874015-19-000045 |
| FY 2017 | $346.0k | 2017-01-01 – 2017-12-31 | evidence 0000874015-19-000045 |
| FY 2016 | $-60.4M | 2016-01-01 – 2016-12-31 | evidence 0000874015-19-000045 |
| FY 2015 | $-88.3M | 2015-01-01 – 2015-12-31 | evidence 0000874015-16-000112 |
| FY 2014 | $-39.0M | 2014-01-01 – 2014-12-31 | evidence 0000874015-16-000112 |
| FY 2013 | $-60.6M | 2013-01-01 – 2013-12-31 | evidence 0000874015-16-000112 |
| FY 2010 | $-61.3M | 2010-01-01 – 2010-12-31 | evidence 0001104659-11-011094 |
| FY 2009 | $155.1M | 2009-01-01 – 2009-12-31 | evidence 0001104659-11-011094 |
| FY 2008 | $-18.2M | 2008-01-01 – 2008-12-31 | evidence 0001104659-11-011094 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Ionis Pharmaceuticals, Inc. — all facts · Revenue · Operating Income